In conclusion, our current study demonstrated that reducing Nm23H1 in ESCC cells may inactivate the AKT signaling pathway and downregulate CLDN1 expression, thereby increase the invasiveness of ESCC cells. The gene discussed is AKT1; the disease is esophageal squamous cell carcinoma.